Please login to the form below

Not currently logged in
Email:
Password:

rheumatoid arthritis

This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.

Gilead and Galapagos JAK contender scores in RA trial

Gilead and Galapagos JAK contender scores in RA trial

Gilead and Galapagos have announced that their oral JAK inhibitor filgotinib has hit its goal in phase III trials in patients with rheumatoid arthritis who have failed on other treatments. ... The FINCH 2 trial of filgotinib in adults with

Latest news

More from news
Approximately 60 fully matching, plus 429 partially matching documents found.

Latest Intelligence

  • Finding the patient voice Finding the patient voice

    rheumatoid arthritis, oncology, psychiatry, cardiovascular diseases, rare diseases etc.

  • The tipping point The tipping point

    In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

  • Mobile health and patient outcomes Mobile health and patient outcomes

    In a recent study in rheumatoid arthritis, patients saw pain as the key measure of treatment success, confounding the objective ‘clinical evidence’of improvement.

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    Pain has nervous and inflammatory components and we are interested in everything around the inflammatory process but also the central nervous system aspect of pain and adjunctive diseases such as rheumatoid ... arthritis and Parkinson’s.

  • Deal Watch December 2016 Deal Watch December 2016

    510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small

More from intelligence
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • Infographic: RA market snapshot

    Infographic: RA market snapshot. An overview of the RA biologic patient. Our RA market snapshot will provide you with an introduction to the treatment pathways followed by RA patients treated with biologic agents. Our analyses are based on 139, 984

  • Living with RA Report

    Living with RA Report. Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.

  • Research Partnership publishes 2016 Living with RA reports

    Research Partnership publishes 2016 Living with RA reports. Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016. ... Living with RA is a quantitative study conducted online amongst 500 patients

  • Infographic: RA Perceptions

    adalimumab) to continue to lead the market and be used to treat over a third of Rheumatoid Arthritis (RA) patients in three years’ time.

  • THE OTHER SIDE OF … RHEUMATOID ARTHRITIS

    THE OTHER SIDE OF … RHEUMATOID ARTHRITIS. “ I harassed my GP enough to get it caught early”. ... Meet Georgie. At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population

More from PMHub
Approximately 9 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics